A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease.

Six subgroups of sporadic Creutzfeldt-Jakob disease have been identified by distinctive clinicopathologic features, genotype at polymorphic codon 129 [methionine (M)/valine (V)] of the PRNP gene, and type of abnormal prion proteins (type 1 or 2). In addition to the pure subgroups, mixed neuropathologic features and the coexistence of two types of abnormal prion proteins in the same patient also have been reported. Here, we found that a portion of the patients previously diagnosed as MM1 had neuropathologic characteristics of the MM2 thalamic form (ie, neuronal loss of the inferior olivary nucleus of the medulla). Furthermore, coexistence of biochemical features of the MM2 thalamic form also was confirmed in the identified cases. In addition, in transmission experiments using prion protein-humanized mice, the brain material from the identified case showed weak infectivity and generated characteristic abnormal prion proteins in the inoculated mice resembling those after inoculation with brain material of MM2 thalamic form. Taken together, these results show that the co-occurrence of MM1 and MM2 thalamic form is a novel entity of sporadic Creutzfeldt-Jakob disease prion strain co-occurrence. The present study raises the possibility that the co-occurrence of the MM2 thalamic form might have been overlooked so far because of the scarcity of abnormal prion protein accumulation and restricted neuropathology.

Low-Energy Bead-Mill Dispersion of Agglomerated Core-Shell α-Fe/Al2O3 and α″-Fe16N2/Al2O3 Ferromagnetic Nanoparticles in Toluene.

Magnetic materials such as α″-Fe16N2 and α-Fe, which have the largest magnetic moment as hard and soft magnetic materials, are difficult to produce as single domain magnetic nanoparticles (MNPs) because of quasistable state and high reactivity, respectively. The present work reports dispersion of agglomerated plasma-synthesized core-shell α″-Fe16N2/Al2O3 and α-Fe/Al2O3 in toluene by a new bead-mill with very fine beads to prepare single domain MNPs. As a result, optimization of the experimental conditions (bead size, rotation speed, and dispersion time) enables the break-up of agglomerated particles into primary particles without destroying the particle structure. Slight deviation from the optimum conditions, i.e., lower or higher dispersion energy, gives undispersed or broken particles due to fragile core-shell structure against stress or impact force of beads. The dispersibility of α″-Fe16N2/Al2O3 is more restricted than that of α-Fe/Al2O3, because of the preparation conditions. Especially for α″-Fe16N2/Al2O3, no change on crystallinity (98% α″-Fe16N2) or magnetization saturation after dispersion was observed, showing that this method is appropriate to disperse α″-Fe16N2/Al2O3 MNPs. A different magnetic hysteresis behavior is observed for well-dispersed α″-Fe16N2/Al2O3 MNPs, and the magnetic coercivity of these NPs is constricted when the magnetic field close to zero due to magnetic dipole coupling among dispersed α″-Fe16N2 MNPs.

Large hypothalamic hamartoma with calcification and cystic components in an adult--case report.

A 24-year-old female presented with an unusual case of hypothalamic hamartoma manifesting as seizure. Neuroimaging findings were atypical, showing the large tumor (maximum diameter, 50 mm) with a cystic component and calcification. Surgery was performed and histological examination demonstrated heterotopia. Hamartoma should be considered in the differential diagnosis of a suprasellar, non-enhanced mass attached to the hypothalamus. Excessive unnecessary surgery should be avoided, and intraoperative pathological examination may lead to enhanced assessment and better outcomes.

Surface plasmon resonance analysis for the screening of anti-prion compounds.

The interaction of anti-prion compounds and amyloid binding dyes with a carboxy-terminal domain of prion protein (PrP121-231) was examined using surface plasmon resonance (SPR) and compared with inhibition activities of abnormal PrP formation in scrapie-infected cells. Most examined compounds had affinities for PrP121-231: antimalarials had low affinities, whereas Congo red, phthalocyanine and thioflavin S had high affinities. The SPR binding response correlated with the inhibition activity of abnormal PrP formation. Several drugs were screened using SPR to verify the findings: propranolol was identified as a new anti-prion compound. This fact indicates that drug screenings by this assay are useful.

Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.

The therapeutic efficacy of direct drug infusion into the brain, the target organ of transmissible spongiform encephalopathies, was assessed in transgenic mice intracerebrally infected with 263K scrapie agent. Pentosan polysulfate (PPS) gave the most dramatic prolongation of the incubation period, and amphotericin B had intermediate effects, but antimalarial drugs such as quinacrine gave no significant prolongation. Treatment with the highest dose of PPS at an early or late stage of the infection prolonged the incubation time by 2.4 or 1.7 times that of the control mice, respectively. PPS infusion decreased not only abnormal prion protein deposition but also neurodegenerative changes and infectivity. These alterations were observed within the brain hemisphere fitted with an intraventricular infusion cannula but not within the contralateral hemisphere, even at the terminal disease stage long after the infusion had ended. Therapeutic effects of PPS were also demonstrated in mice infected with either RML agent or Fukuoka-1 agent. However, at doses higher than that providing the maximal effects, intraventricular PPS infusion caused adverse effects such as hematoma formation in the experimental animals. These findings indicate that intraventricular PPS infusion might be useful for the treatment of transmissible spongiform encephalopathies in humans, providing that the therapeutic dosage is carefully evaluated.